Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC.
Kono Y, Piscaglia F, Wilson SR, Medellin A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Sidhu PS, Wessner CE, Bradigan K, Kuon Yeng Escalante CM, Siu Xiao T, Eisenbrey JR, Forsberg F, Lyshchik A; CEUS LI-RADS Trial Group.
Kono Y, et al.
Abdom Radiol (NY). 2024 Jun 11. doi: 10.1007/s00261-024-04305-9. Online ahead of print.
Abdom Radiol (NY). 2024.
PMID: 38860996
Free article.